Secretion of RTX leukotoxin by Actinobacillus actinomycetemcomitans

被引:84
作者
Kachlany, SC
Fine, DH
Figurski, DH
机构
[1] Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA
[2] Univ Med & Dent New Jersey, Dept Oral Biol & Pathol, Newark, NJ 07103 USA
关键词
D O I
10.1128/IAI.68.11.6094-6100.2000
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Actinobacillus actinomycetemcomitans, the etiologic agent for localized juvenile periodontitis and certain other human infections, such as endocarditis, expresses a leukotoxin that acts on polymorphonuclear leukocytes and macrophages. Leukotoxin is a member of the highly conserved repeat toxin (RTX) family of bacterial toxins expressed by a variety of pathogenic bacteria. While the RTX toxins of other bacterial species are secreted, the leukotoxin of A. actinomycetemcomitans is thought to remain associated with the bacterial cell. We have examined leukotoxin production and localization in rough (adherent) and smooth (nonadherent) strains of A. actinomycetemcomitans. We found that leukotoxin expressed by the rough, adherent, clinical isolate CU1000N is indeed cell associated, as expected. However, we were surprised to find that smooth, nonadherent strains of A. actinomycetemcomitans, including Y4, JP2 (a strain expressing a high level of toxin), and CU1060N tan isogenic smooth variant of CU1000N), secrete an abundance of leukotoxin into the culture supernatants during early stages of growth. After longer times of incubation, leukotoxin disappears from the supernatants, and its Loss is accompanied by the appearance of a number of low-molecular-weight polypeptides. The secreted leukotoxin is active, as evidenced by its ability to kill HL-60 cells in vitro. We found that the growth phase and initial pH of the growth medium significantly affect the abundance of secreted leukotoxin, and we have developed a rapid (<2 h) method to partially purify large amounts of leukotoxin. Remarkably, mutations in the tad genes, which are required for tight nonspecific adherence of A. actinomycetemcomitans to surfaces, cause leukotoxin to be released from the bacterial cell. These studies show that A. actinomycetemcomitans has the potential to secrete abundant leukotoxin. It is therefore appropriate to consider a possible role for leukotoxin secretion in the pathogenesis of A. actinomycetemcomitans.
引用
收藏
页码:6094 / 6100
页数:7
相关论文
共 64 条
[21]   ACTIVATION OF ESCHERICHIA-COLI PROHAEMOLYSIN TO THE MATURE TOXIN BY ACYL CARRIER PROTEIN-DEPENDENT FATTY ACYLATION [J].
ISSARTEL, JP ;
KORONAKIS, V ;
HUGHES, C .
NATURE, 1991, 351 (6329) :759-761
[22]   Nonspecific adherence by Actinobacillus actinouaycetemcomitans requires genes widespread in Bacteria and Archaea [J].
Kachlany, SC ;
Planet, PJ ;
Bhattacharjee, MK ;
Kollia, E ;
DeSalle, R ;
Fine, DH ;
Figurski, DH .
JOURNAL OF BACTERIOLOGY, 2000, 182 (21) :6169-6176
[23]   Codon usage in Actinobacillus actinomycetemcomitans [J].
Kaplan, JB ;
Fine, DH .
FEMS MICROBIOLOGY LETTERS, 1998, 163 (01) :31-36
[24]   Characterization of Actinobacillus actinomycetemcomitans leukotoxin pore formation in HL60 cells [J].
Karakelian, D ;
Lear, JD ;
Lally, ET ;
Tanaka, JC .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1998, 1406 (02) :175-187
[25]   CLONING AND EXPRESSION OF THE LEUKOTOXIN GENE FROM ACTINOBACILLUS-ACTINOMYCETEMCOMITANS [J].
KOLODRUBETZ, D ;
DAILEY, T ;
EBERSOLE, J ;
KRAIG, E .
INFECTION AND IMMUNITY, 1989, 57 (05) :1465-1469
[26]   PROTEIN EXPORTER FUNCTION AND IN-VITRO ATPASE ACTIVITY ARE CORRELATED IN ABC-DOMAIN MUTANTS OF HLYB [J].
KORONAKIS, E ;
HUGHES, C ;
MILISAV, I ;
KORONAKIS, V .
MOLECULAR MICROBIOLOGY, 1995, 16 (01) :87-96
[27]   Synthesis, maturation and export of the E-coli hemolysin [J].
Koronakis, V ;
Hughes, C .
MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 1996, 185 (02) :65-71
[28]  
Koronakis V, 1993, Semin Cell Biol, V4, P7, DOI 10.1006/scel.1993.1002
[29]   ATPASE ACTIVITY AND ATP/ADP-INDUCED CONFORMATIONAL CHANGE IN THE SOLUBLE DOMAIN OF THE BACTERIAL PROTEIN TRANSLOCATOR HLYB [J].
KORONAKIS, V ;
HUGHES, C ;
KORONAKIS, E .
MOLECULAR MICROBIOLOGY, 1993, 8 (06) :1163-1175
[30]  
Korostoff J, 1998, INFECT IMMUN, V66, P4474